C Champions Oncology Inc
C
Geschlossen
BrancheGesundheitswesen
4.83 0.84
Übersicht
Veränderung der Aktienkurses
24h
Min
4.79
Max
4.83
Einkommen | 241K -426K |
|---|---|
Verkäufe | 1.4M 15M |
KGV Branchendurchschnitt | 35.118 47.946 |
EPS | -0.03 |
Gewinnspanne | -2.797 |
Angestellte | 214 |
EBITDA | 79K -95K |
Nächstes Ergebnis | 14. Dez. 2026 |
|---|
Marktkapitalisierung | -3.3M 69M |
|---|---|
Vorheriger Eröffnungskurs | 3.99 |
Vorheriger Schlusskurs | 4.83 |
Champions Oncology Inc Chart
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
Ähnliche Nachrichten
Peer-Vergleich
Kursveränderung
Champions Oncology Inc Prognose
Finanzen
Vertriebs- und Verwaltungskosten
Betriebsaufwand
Gewinn vor Steuern
Verkäufe
Umsatzkosten
Bruttogewinn aus dem Verkauf
Zinsaufwand für Schulden
EBITDA
Betriebsergebnis
$
Über Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.